Mazdutide Compared to Dulaglutide in Chinese Type 2 Diabetes Patients
TL;DR Summary
A phase 3 study in Chinese adults with type 2 diabetes found that mazdutide, a dual glucagon and GLP-1 receptor agonist, was more effective than dulaglutide in reducing HbA1c and body weight over 28 weeks, with manageable gastrointestinal side effects.
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
94%
672 → 40 words
Want the full story? Read the original article
Read on Nature